Drugmakers Urge Changes to FDA Draft Guidance on Continuous Manufacturing

Drug Industry Daily
A A
Leading drug manufacturers and trade groups are calling for modifications to the FDA’s draft guidance on continuous manufacturing quality considerations.

To View This Article:

Login

Subscribe To Drug Industry Daily